The United States Food and Drug Administration (FDA) recently announced that it had approved Profound Medical’s Sonalleve MR-guided High Intensity Focused Ultrasound (MR-HIFU) system for the treatment of osteoid osteoma (OO) in the extremities. This marks the first focused ultrasound regulatory approval that will directly impact pediatric patients, and it is the sixth indication to earn approval in the US.
NEO.LIFE recently published an in-depth article titled, “The Focus of His Energy,” highlighting the technology, the Foundation, and its founder and chairman, Neal F. Kassell, MD.
We hosted a virtual media event to educate top tier media on the use of focused ultrasound to treat conditions such as Parkinson’s disease, cancer, and psychiatric disorders.
Researchers in Toronto are investigating the safety of a second focused ultrasound treatment. Essential tremor patients who were treated successfully on one side will receive a second procedure on the other.
Foundation Council member Harry Lester shares his Stage IV lung cancer diagnosis, his experience with immunotherapy, and his hope for focused ultrasound to increase the effectiveness of cancer treatments.
Beginning in April 2021, the National Health Service (NHS) England – the country’s publicly funded healthcare system – has commissioned focused ultrasound as a clinical service to treat essential tremor.
A collaborative research group measured the beta-amyloid plaque changes in six patients with Alzheimer’s disease who underwent focused ultrasound—based blood-brain barrier opening.
Elisa Konofagou, PhD, and her research team at Columbia University recently treated the first patient in their clinical trial to open the blood-brain barrier in patients with Alzheimer’s disease using a novel, neuronavigation-guided focused ultrasound system.
A team at the University of Virginia has joined a multicenter clinical trial evaluating the safety of using focused ultrasound to enhance the delivery of chemotherapy in patients with glioblastomas.
Researchers in the US have published results showing focused ultrasound to be a safe and feasible treatment for the motor fluctuations and dyskinesias from Parkinson’s disease.
The Foundation’s Brain Clinical Program will fund a project by Shiro Horisawa, MD, using focused ultrasound to treat patients with cervical dystonia, a painful neck condition.
Tao Sun, PhD, a Research Fellow in Radiology at Harvard Medical School/Brigham and Women’s Hospital seeks abstracts for a video methods collection on focused ultrasound for neurological disorders.
CarThera was awarded a €2 million grant from the European Innovation Council Accelerator Pilot to finish developing its SonoCloud-9 device for treating glioblastoma patients. A multicenter pilot clinical study for the device is underway.
EDAP TMS has agreed to an exclusive distribution deal with AB Medica, a move that will extend the availability of the company’s HIFU technology to one of the largest European markets.
The recent focal therapy prostate study published in the Journal of Urology primarily used Sonablate HIFU technology. See media coverage in Urology Times.
The International Society for Therapeutic Ultrasound’s final webinar of 2020 will feature Professor Gail ter Haar presenting, “History of Focused Ultrasound."
